SCHEMBL3645452

SCHEMBL3645452

O=C(NC1(CCCO)CCC1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.53
CTSL P07711 2/20 0.43
LMNA P02545 1/20 0.42
CTSK P43235 1/20 0.42
FAAH O00519 1/20 0.42
HTT P42858 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
ALDH1A1 P00352 2/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
APAF1 O14727 1/20 0.40
TDP2 O95551 1/20 0.40
NSD2 O96028 1/20 0.40
ABL1 P00519 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
MAPT P10636 1/20 0.40
CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10604425 0.87 ADRB2 (0.52) ADRB2CTSLLMNACTSKFAAH
SCHEMBL10604416 0.85 ADRB2 (0.51) ADRB2CTSLLMNACTSK
SCHEMBL10607231 0.84 NAAA (0.52) ADRB2CTSLCTSK
SCHEMBL10604253 0.83 ADRB2 (0.55) ADRB2CTSLLMNACTSKFAAH
SCHEMBL10607221 0.80 ADRB2 (0.57) ADRB2CTSLLMNACTSKFAAH
SCHEMBL1186102 0.80 ADRB2 (0.57) ADRB2CTSLLMNACTSKFAAH
SCHEMBL27794391 0.79 ADRB2 (0.60) ADRB2CTSLLMNACTSKFAAH
SCHEMBL10610238 0.78 ADRB2 (0.76) ADRB2CTSLLMNACTSKFAAH
SCHEMBL1185448 0.77 ADRB2 (0.55) ADRB2CTSLLMNACTSKFAAH
SCHEMBL1187444 0.77 ADRB2 (0.55) ADRB2CTSLLMNACTSKFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203459-A1 SPIROCYCLIC AMINOQUINOLONES AS GSK-3 INHIBITORS Activx Biosciences, Inc. (US) 2010-07-07 EP disclosed
WO-2009035684-A1 SPIROCYCLIC AMINOQUINOLONES AS GSK-3 INHIBITORS ACTIVX BIOSCIENCES, INC. (US) 2009-03-19 WO disclosed